How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

923 results for

Anxiety Non-pharmacologic Management

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

121. The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence Full Text available with Trip Pro

gastroenterology clinics. Our review shows experts do not agree on a universally proven management that will work on every child presenting with functional abdominal pain (FAP). Treatment strategies include both non-pharmacological and pharmacological options. Non-pharmacological treatments are usually very well accepted by both children and their parents and are free from medication side effects. Nevertheless, they may be as effective as the pharmacological interventions; therefore, according to many experts (...) The Management of Paediatric Functional Abdominal Pain Disorders: Latest Evidence Recurrent abdominal pain (RAP) is one of the most common health complaints in both children and adults. Although RAP is considered a functional disorder rather than an organic disease, affected children and their families can still experience anxiety and concerns that can interfere with school, sports, and regular daily activities and lead to frequent attendances at pediatric emergency departments or pediatric

2018 Paediatric Drugs

122. Spinal Manipulation and Patient Self-Management for Preventing Acute to Chronic Back Pain

is to reduce overall low back pain (LBP) burden by testing scalable, first-line, non-pharmacologic strategies that address the biopsychosocial aspects of acute/sub-acute LBP and prevent transition to chronic back pain. The US is in the midst of an unprecedented pain management crisis. LBP is the most common chronic pain condition in adults and the leading cause of disability worldwide. Guidelines have recommended non-pharmacologic treatments like spinal manipulation and behavioral approaches for LBP (...) for nearly a decade, yet uptake and adherence has been poor. Moreover, little is known about the role of these treatments in the secondary prevention of chronic LBP (cLBP), especially for patients with biopsychosocial risk factors. With burgeoning costs, mounting evidence of ineffectiveness, and harms of commonly used drug treatments, including opioids, there is a critical need for research on non-pharmacological treatments for cLBP prevention that can be readily translated to practice. Condition

2018 Clinical Trials

123. A Community-Based Chronic Pain Self-Management Program in West Virginia

, and opioid overdose deaths have quadrupled, yet with no overall change in pain. Although one-third of US adults have CP, there is a lack of affordable, non-pharmacological, evidence-based, community-delivered interventions for people with CP. One program, the Chronic Pain Self-Management Program (CPSMP), provides short-term improvements in pain but its long-term effects have not been evaluated. This study will examine the long-term effects of CPSMP in the medically underserved state of West Virginia (WV (...) , interference, medication use), mental health (mood, anxiety, catastrophizing), function (self-efficacy, coping, health-related quality of life, sleep, fatigue, communication, physical activity), healthcare utilization, missed work days, and gait speed. Condition or disease Intervention/treatment Phase Chronic Pain Behavioral: Chronic Pain Self-Management Program (CPSMP) Not Applicable Detailed Description: Chronic pain (CP) affects 1 in 3 US adults and costs up to $635 billion annually in medical costs

2018 Clinical Trials

124. NSS-2 BRIDGE Device in Post-Operative Pain Management

-operative pain management. As compared to the present use of opioids for perioperative pain management, the use of a complementary, non-pharmacologic approach offers the advantage of analgesia without the associated side effects. Condition or disease Intervention/treatment Phase Acute Pain Surgery Abdominal Cancer Device: NSS-2 Bridge Device: Sham NSS-2 BRIDGE Not Applicable Study Design Go to Layout table for study information Study Type : Interventional (Clinical Trial) Estimated Enrollment : 60 (...) by (Responsible Party): Jacques E. Chelly, University of Pittsburgh Study Details Study Description Go to Brief Summary: The current opioid epidemic has led to a renewed interest in exploring non-pharmacological techniques to treat post-operative pain. An increasing number of patients are suffering from the adverse effects of opioid use following surgery, including post-operative nausea and vomiting, respiratory depression, immunosuppression, constipation, and most recently, addiction. In the United States

2018 Clinical Trials

125. Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD

to RR&D's current special areas of interest for non-pharmacological activity-based interventions for chronic pain impacting pain reduction, function and quality of life. This project aligns with the VA mandate for complementary and integrative health (CIH) care for Veterans and their families. CIH complements traditional care for Veterans managing chronic conditions, such as chronic pain and PTSD. Mission Reconnect (MR) is a user-driven, dyadic, CIH self-care management program delivered remotely (...) to CIH for pain and self-care management as a priority to achieve optimal Veteran health. To be responsive to these priorities the 2016 VA State-of-the-Art Conference (SOTA) and Comprehensive Addiction Recovery Act (CARA) mandated VA's commitment to conduct rigorous research to integrate non-pharmacological and CIH approaches into care, with emphasis on pain management. This proposal is also responsive to the VA's Opioid Safety Initiative (OSI) and Pain Care Mission which prioritize the need

2018 Clinical Trials

126. Pilot Study of a Robot-assisted Intervention for the Management of Care-induced Pain in Dementia

with cognitive impairments can cause anxiety and behavioral problems.The aim of this study is to demonstrate that a systematic identification of pain associated with the use of social robots such as the PARO robot may contribute to a better anticipation and management of care-induced pain. The investigators hypothesize that an individual use of the PARO robot would bring relaxation to the patient, a distraction regarding the aversive situation of care and, thus, it would prevent manifestations of acute pain (...) of the International Psychogeriatric Association (IPA) is the use of psychosocial approaches as first-line therapy for behavioral problems in persons with dementia. Indeed, a wide range of non-pharmacological interventions for persons with dementia exist, such as biofeedback, music therapy, therapeutic touch or relaxation. Most of these interventions have shown positive results on health status, quality of life, socialization, and functional capacity in dementia. However, to date, little is known on the effect

2018 Clinical Trials

127. A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants

A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (...) (100). Please remove one or more studies before adding more. A Randomized Controlled Trial of Three Non-pharmacologic Analgesic Techniques for Casting of Clubfoot Infants The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our for details. ClinicalTrials.gov Identifier: NCT02395185 Recruitment Status : Completed First Posted : March 20, 2015 Results

2015 Clinical Trials

128. The impact of dental treatment and age on salivary cortisol and alpha-amylase levels of patients with varying degrees of dental anxiety. Full Text available with Trip Pro

The impact of dental treatment and age on salivary cortisol and alpha-amylase levels of patients with varying degrees of dental anxiety. The purpose of this study was to assess the salivary cortisol and salivary alpha-amylase levels in children aged between 6 and 9 years, 3 months and 1 year after the successful completion of dental treatment through either pharmacological or non-pharmacological behavior management techniques.A total of 1567 patients aged between 6 and 9 years who had completed (...) . There was no significant difference between the salivary cortisol levels of anxious and phobic patients. These findings were replicated on 1-year recall.Within the limitations of this study we can conclude that salivary amylase is an indicator of of acute stress that can differentiate between anxiety and dental fear; while salivary cortisol appears to be a marker of long-term stress that lacks the sensitivity to differentiate between the two.

2019 BMC Oral Health

129. 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes Full Text available with Trip Pro

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies (...) . By continuing to browse this site you are agreeing to our use of cookies. Free Access article Share on Jump to Free Access article 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines , MD, FACC , MD, MACC, FAHA , MD, MPH, MACC, FSCAI , MD, MPH, MBA, FACP, FAHA , MD , MD, MACC , MD, FACC, FAHA , MD, FACC, FAHA, FSCAI , MD , MD, FACC, FAHA , MD, FACC

2014 American Heart Association

130. Management of Heart Failure  (3rd Edition)

. • It is important to determine and treat the underlying etiology. Common causes are coronary artery disease and hypertension. • Prevention and early intervention wherever appropriate, should be the primary objective of management. • For the management of Acute HF and Chronic HF and grades of recommendations, see Flow Chart I, pg 10 and Table 1, pg 11 and Flow chart II, pg 12 and Table 2, pg 13 respectively • Non pharmacological measures involves counseling the patient and family about the disease, diet (...) Failure 7.2.1 Non Pharmacological Measures 30 - 32 7.2.2 Pharmacological Management 32 - 38 7.2.3 Device Therapy In Heart Failure 39 - 40 7.2.4 Surgery for Heart Failure 40 - 41 7.2.5 Heart Transplantation 41 7.3 Special Groups 7.3.1 Asymptomatic Left Ventricular Dysfunction 42 - 43 7.3.2 Heart Failure With Preserved Left 43 - 45 Ventricular Systolic Function 7.3.3 Heart Failure in Pregnancy 45 - 48 7.3.4 Heart Failure in Infants and Children 48 - 53 7.3.5 Refractory Heart Failure 53 7.3.6 End of Life

2014 Ministry of Health, Malaysia

131. Management of Chronic Obstructive Pulmonary Disease (COPD)

of the disease process and novel drugs. Furthermore, non-pharmacologic therapy such as pulmonary rehabilitation is becoming increasingly recognized as an effective therapy. [16] While these treatment methods may not all be appropriate for all patients, they allow providers to intervene early with numerous treatment options in order to help benefit patients. The increasing amount of COPD research leading to further understanding of the disease and effective management strategies allows patients and providers (...) . It includes Veterans and deployed and non-deployed active duty Service Members. The population includes adults with a diagnosis or a suspicion of COPD. Patients with bronchiectasis, asthma, cystic fibrosis, or other chronic lung diseases but without COPD are not considered in this CPG. Interventions and Management Methods Interventions covered in this CPG include inhaled and systemic pharmacologic treatments as well as non-pharmacologic treatments used in acute and maintenance management of COPD

2014 VA/DoD Clinical Practice Guidelines

132. The Non-Surgical Management of Hip & Knee Osteoarthritis (OA)

of a patient’s management plan. Lastly, the primary care provider may consider referral Page 6 of 126 Clinical Practice Guideline for the Non-Surgical Management of Osteoarthritis for surgical evaluation for OA patients that do not find relief through pharmacologic and/or non- pharmacologic therapies. The goal of this guideline is to assist primary care providers in developing a comprehensive care program for patients with OA in order to achieve maximum functionality and independence, as well as improve (...) a minimum of five percent body weight and maintain this new level of weight. [EO] Discussion It is well-established in previously published guidelines that weight reduction is a cornerstone of non- pharmacologic therapy for the management of hip or knee OA. A review of the literature revealed two well-designed RCTs in which patients with knee OA self-reported improvements in pain and disability after losing weight. [35,36] It is also noted that patients who engaged in exercise or weight loss programs

2014 VA/DoD Clinical Practice Guidelines

133. Management of Obesity and Overweight

on the patient-centered approach to weight loss, the benefits and harms of pharmacologic and non-pharmacologic therapies, the management of comorbid conditions, best practices for care delivery, and emerging innovations in clinical research and care. Key Elements of Weight Loss and Management The key elements of weight loss and weight management that are addressed by this guideline include: • Obesity is a chronic disease requiring lifelong commitment to treatment and long-term maintenance • Obesity may (...) does not provide recommendations for the treatment of children, adolescents, or pregnant/lactating women. Interventions This CPG provides information on both pharmacologic and non-pharmacologic therapies for overweight and obesity. Pharmacologic therapies are limited to available Food and Drug Administration (FDA) approved medications that are specifically indicated for use in treating overweight and/or obesity. These include lorcaserin, orlistat, or the combination phentermine/topiramate extended

2014 VA/DoD Clinical Practice Guidelines

134. The Management of Upper Extremity Amputation Rehabilitation (UEAR)

on the rehabilitation plan and the patient’s physical and psychological status. EO 9. Various types of pain following upper limb loss should be managed appropriately and individually throughout all phases using pharmacological and non-pharmacological treatment options. EO 10. The care team should provide appropriate education and informational resources to patients, family and caregiver(s) throughout all phases of care. EO 11. The care team should facilitate early involvement of a trained peer visitor. C (...) activities) • Improve quality of life and decrease activity restriction (e.g., optimize self-care, community integration, recreation, return to home and productive work environments) Psychological support and wellbeing • Reduce psychological comorbidities (e.g., depressive and anxiety disorders) VA/DoD Evidence-Based Clinical Practice Guideline for the Management of Upper Extremity Amputation Rehabilitation Page 10 of 149 Domain Goals • Improve quality of life • Decrease the mental/emotional disease

2014 VA/DoD Clinical Practice Guidelines

135. The Management of Chronic Multisymptom Illness

and non-pharmacologic therapies, the management of comorbid conditions, best practices for care delivery, and emerging innovations in clinical research and care. The overall expected outcome of successful implementation of this guideline is to: • Formulate an efficient and effective assessment of the patient's condition • Optimize the use of therapy to reduce symptoms and enhance functionality • Minimize preventable complications and morbidity • Emphasize the use of personalized, proactive, patient (...) Members. This CPG does not provide recommendations for the treatment of CMI in children or adolescents. Intervention This CPG provides information on potential risk factors for CMI, diagnostic technologies that may be used for screening and assessment of CMI, management of CMI, and pharmacologic and non- pharmacologic therapies for the treatment of CMI. Risk factors that may be associated with predisposing, precipitating, and perpetuating CMI include medical (e.g., comorbidities), psychological (e.g

2014 VA/DoD Clinical Practice Guidelines

136. Screening, Assessment, and Management of Fatigue in Adult Survivors of Cancer Guideline Adaptation Full Text available with Trip Pro

care professionals who provide care to adults with cancer. The guideline is interprofessional in focus, and the recommendations are applicable to direct-care providers (eg, nurses, social workers, family practitioners) in diverse care settings. The NCCN Guideline for Cancer-Related Fatigue describes procedures for the assessment and management of fatigue in patients with cancer. The target population includes children, adolescents, and adults, and the guideline is intended to provide guidance (...) be a late or long-term problem in post-treatment survivors. SPECIAL COMMENTARY Section: Although there are a number of guidelines and systematic reviews offering recommendations on the management of cancer-related fatigue, there is still relatively little guidance available for the management of fatigue in cancer survivors. The purpose of this guideline is to tailor the available information to this distinct population, because follow-up care for cancer survivors is often challenging, especially

2014 American Society of Clinical Oncology Guidelines

137. Guidelines for identification and management of substance use and substance use disorders in pregnancy

who are stable on opioid maintenance treatment with either methadone or buprenorphine should be encouraged to breastfeed unless the risks clearly outweigh the benefits. Strong Low Management of infants exposed to alcohol and other psychoactive substances ? Health-care facilities providing obstetric care should have a protocol in place for identifying, assessing, monitoring and intervening, using non-pharmacological and pharmacological methods, for neonates prenatally exposed to opioids. Strong (...) treatment, or opioid substitution treatment. Examples of opioid maintenance therapies are methadone and buprenorphine maintenance treatment. Maintenance treatment can last from several months to more than 20 years, and is often accompanied by other treatment (e.g. psychosocial treatment). Psychosocial intervention Any non-pharmacological intervention carried out in a therapeutic context at an individual, family or group level. Psychosocial interventions range from structured, professionally administered

2014 World Health Organisation Guidelines

138. Neurofeedback and Biofeedback for Post-Traumatic Stress Disorder, Generalized Anxiety Disorder, and Depression: A Review of the Clinical Evidence and Guidelines

. DATE: 15 June 2012 CONTEXT AND POLICY ISSUES Post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), and depression are psychiatric disorders that interfere with daily-life activities and need psychological and pharmacological treatments. 1-3 Approximately, 5.7 % of Canadians 18 years and older are affected by GAD, 6.8% by PTSD, and 4.8% by major depression. 1,4 Biofeedback therapies are non-pharmacological treatments that use non-invasive techniques with bio-monitoring system (...) -related post-traumatic stress disorder. Biofeedback may have some efficacy in patients with generalized anxiety disorder. Findings from larger size randomized placebo-controlled trials with alternative therapies as the comparator are needed to confirm the potential of biofeedback and neurofeedback, and to develop guidelines regarding the use of these non-pharmacological and non-invasive modalities for the treatment of mood and anxiety disorders. PREPARED BY: Canadian Agency for Drugs and Technologies

2012 Canadian Agency for Drugs and Technologies in Health - Rapid Review

139. 2013 ACCF/AHA Guideline for the Management of Heart Failure Full Text available with Trip Pro

2013 ACCF/AHA Guideline for the Management of Heart Failure 2013 ACCF/AHA Guideline for the Management of Heart Failure | Circulation Search Hello Guest! Login to your account Email Password Keep me logged in Search March 2019 March 2019 March 2019 March 2019 March 2019 February 2019 February 2019 February 2019 February 2019 January 2019 January 2019 January 2019 January 2019 January 2019 This site uses cookies. By continuing to browse this site you are agreeing to our use of cookies. Free (...) Access article Share on Jump to Free Access article 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , , MD, MSc, FACC, FAHA, Chair , MD, FACC, FAHA, Vice Chair , MD, PhD, FACC, FAHA , MBBS, FACC, FAHA , MD, MPH, MBA, FACP, FAHA , MD, MSc, FACC, FAHA , MD, FACC, FAHA , MD, FACC, FAHA, FCCP , MD, FACC , MD, FACC , MD, FACC, FAHA , MD, FACC, FAHA , MD, FACC , MD, MSPH, FACC

2013 American Heart Association

140. Assessment and Management of Pain (Third Edition)

analgesics; and ¦ Prevention, assessment and management of opioid risk . Ib ? Recommendation 3 .2 Evaluate any non-pharmacological (physical and psychological) interventions for effectiveness and the potential for interactions G with pharmacological interventions . Ib ? Recommendation 3 .3 Teach the person, their family and caregivers about the pain management strategies in their plan of care and address known concerns and misbeliefs G . Ib ?9 BEST PRACTICE GUIDELINES • www.RNAO.ca BACKGROUND Assessment (...) Assessment and Management of Pain (Third Edition) Clinical Best Practice Guidelines DECEMBER 2013 Assessment and Management of Pain Third EditionDisclaimer These guidelines are not binding on nurses or the organizations that employ them. The use of these guidelines should be flexible, and based on individual needs and local circumstances. They neither constitute a liability nor discharge from liability. While every effort has been made to ensure the accuracy of the contents at the time

2013 Registered Nurses' Association of Ontario

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>